Combined diagnostic kit based on CCL8, CCL26 and CXCL6 genes and applied to glioblastoma and use method of combined diagnostic kit
A glioblastoma, CCL26 technology, applied in biochemical equipment and methods, microbial assay/test, etc., can solve the problem of unreported expression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment
[0037] The experimental methods in the following examples are conventional methods unless otherwise specified, and the experimental reagents and materials involved are conventional biochemical reagents and materials unless otherwise specified.
[0038] 1. Differential expression of CCL8, CCL26 and CXCL6 in LGG and GBM compared with TCGA database
[0039] The Cancer Genome Atlas (TCGA) project team was originally composed of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), and developed into A very large data research platform. Low-grade glioma (LGG) and glioblastoma (GBM), as one of the earliest tumors studied, have a large number of comprehensive data results. The LGG and GBM data in TCGA come from (https: / / genome-cancer.ucsc.edu), in which LGG included 530 tumor samples, and GBM included 167 samples. The results of CCL8 gene transcription level are from the RNA-seq results of the Illumina HiSeq sequencing platform. figure 1 It ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



